Artwork

Content provided by Drug Science. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Drug Science or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

104. Psychedelics in New Zealand with Dr Suresh Muthukumaraswamy

45:23
 
Share
 

Manage episode 419547442 series 2528839
Content provided by Drug Science. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Drug Science or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, we meet with Dr. Suresh Muthukumaraswamy, an Associate Professor of Pharmacy in Auckland. Dr. Muthukumaraswamy discusses his early research, exploring the functional connectivity of substances like DMT and Ketamine. He proceeds to share insights into his breakthrough realisation regarding the disparity between the self-reported success of microdosing outside the lab setting and why it has failed to be replicated in controlled research settings. Finally, he shares his opinions on recent developments of drug policy in Australia and the prospects of New Zealand adopting a similar policy.

Ketamine

DMT

LSD

Fmri

MEG

EEG

PET

5-HT Receptor

Microdosing

Neuroplasticity

Endocrine

Menstural Cycle Hormones

Australia Law on MDMA and Psilocybin

Research

Support the podcast

★ Support this podcast ★
  continue reading

137 episodes

Artwork
iconShare
 
Manage episode 419547442 series 2528839
Content provided by Drug Science. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Drug Science or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, we meet with Dr. Suresh Muthukumaraswamy, an Associate Professor of Pharmacy in Auckland. Dr. Muthukumaraswamy discusses his early research, exploring the functional connectivity of substances like DMT and Ketamine. He proceeds to share insights into his breakthrough realisation regarding the disparity between the self-reported success of microdosing outside the lab setting and why it has failed to be replicated in controlled research settings. Finally, he shares his opinions on recent developments of drug policy in Australia and the prospects of New Zealand adopting a similar policy.

Ketamine

DMT

LSD

Fmri

MEG

EEG

PET

5-HT Receptor

Microdosing

Neuroplasticity

Endocrine

Menstural Cycle Hormones

Australia Law on MDMA and Psilocybin

Research

Support the podcast

★ Support this podcast ★
  continue reading

137 episodes

Alle episoder

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide